Stephen J.LurieMD, PhD, Senior EditorIndividualAuthor
Copyright 2002 American Medical Association. All Rights Reserved.
Applicable FARS/DFARS Restrictions Apply to Government Use.2002
To the Editor: In her Editorial accompanying
our article1 about prognostic factors for
lung transplantation among patients with cystic fibrosis (CF), Dr Maurer2 noted that we did not comment on the survivorship
effect of the rate of change in the FEV1%.
Liou TG, Adler FR, Cahill BC, FitzSimmons SC, Huang D, Hibbs JR, Marshall BC. Priorities for Lung Transplantation Among Patients With Cystic Fibrosis. JAMA. 2002;287(12):1523-1525. doi:10.1001/jama.287.12.1523